Cover image of the article: Does Myocardial Scan with Technetium Lead to Radio Adaptive Response Among Patients Who Are Undergoing Thallium Scan? (Cytogenetic Study)

Image Credit:I J Radiol

Does Myocardial Scan with Technetium Lead to Radio Adaptive Response Among Patients Who Are Undergoing Thallium Scan? (Cytogenetic Study)

Authors

Mohammmad Mehdi Shirazi1,*, Ali Shabestani Monfared1, Maryam Shahidi2, Mehrangiz Amiri1
1Babol University of Medical Sciences, Babol, Iran
2Mazandaran University of Medical Sciences, Mazandaran, Iran
*Corresponding Author: Babol University of Medical Sciences, Babol, Iran, Shirazi_1200@yahoo.com. Email: Shirazi_1200@yahoo.com

Iranian Journal of Radiology:Vol. 14, issue Special Issue; e48207
Published online:Apr 12, 2017
Article type:Abstract
Received:Dec 20, 2016
Accepted:Feb 07, 2017
How to Cite:Shirazi MM, Shabestani Monfared A, Shahidi M, Amiri M. Does Myocardial Scan with Technetium Lead to Radio Adaptive Response Among Patients Who Are Undergoing Thallium Scan? (Cytogenetic Study). I J Radiol. 2017;14(Special Issue):e48207. doi: https://doi.org/10.5812/iranjradiol.48207

Abstract

Background:

Low dose radiation will induce adaptation and following exposure to an adaptive dose, the cells are more resistance to following challenging doses. This phenomenon is known as radio-adaptive response. The aim of this study was to investigate the percentage of apoptotic cells in the peripheral blood samples of the patients which undergo myocardial perfusion imaging with Tc-99m prior to thallium scan to assess the induction of radio-adaptive response.

Methods:

97 samples from 74 patients, referred to nuclear medicine center of Mazandaran heart hospital for myocardial perfusion imaging which had no history of diagnostic, therapeutic, occupational and radioactive exposures during past two years, were provided. The participants were classified into four groups including control, technetium, thallium and the last group were the patients that examined by technetium followed by thallium. Then 2 mL Peripheral blood samples were obtained, the samples were studied by neutral comet assay with one-way ANOVA.

Results:

The mean percent of apoptotic cells in the groups 2, 3, 4 were more than the controls and the mean percent of apoptotic cells in the patients who examined with 201Tl were more than other groups but the mean percent of apoptotic cells in the group 4 (99mTc before 201Tl) was less than that group 3(just examinated by 201Tl) and this difference was significant statistically.

Conclusions:

These findings suggest that exposure to Tc-99m could induce a radio-adaptive response against the exposure of Tl-201.

Highlights

Full Text

Full text is available in PDF

Copyright

© 2017, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.

Similar Articles

16
Jun
2022
Investigation of the Clinical Efficacy of 99mTc-Sestamibi Washout in Patients with Acute Myocardial Infarction and Comparison with Stress Myocardial Imaging with 99mTc-Sestamibi Using a Two-Day Protocol

Investigation of the Clinical Efficacy of 99mTc-Sestamibi Washout in Patients with Acute Myocardial Infarction and Comparison with Stress Myocardial Imaging with 99mTc-Sestamibi Using a Two-Day Protocol

Mieko Ota,
Fuminori Hyodo,
Shinro Matsuo,
Takashi Kato,
Nobuyuki Kawai,
Fumihiko Nakamura
,et al.

Ota M, Hyodo F, Matsuo S, Kato T, Kawai N, et al. Investigation of the Clinical Efficacy of 99mTc-Sestamibi Washout in Patients with Acute Myocardial Infarction and Comparison with Stress Myocardial Imaging with 99mTc-Sestamibi Using a Two-Day Protocol. I J Radiol. 2022;19(2):e122423. doi: https://doi.org/10.5812/iranjradiol-122423

31
Jul
2008
Radioiodine Therapy Induced Cytotoxicity in Patients with Differentiated Thyroid Carcinoma

Radioiodine Therapy Induced Cytotoxicity in Patients with Differentiated Thyroid Carcinoma

A Hooman,
M Mogharrabi,
M Solooki,
N Mosaffa,
F Tabeie,
B Shafiee
,et al.

Hooman A, Mogharrabi M, Solooki M, Mosaffa N, Tabeie F, et al. Radioiodine Therapy Induced Cytotoxicity in Patients with Differentiated Thyroid Carcinoma. Int J Endocrinol Metab. 2008;6(3):. doi:

31
Mar
2010
The efficacy of biomarkers indexes in comparison with Echocardiography in assessment of antracycline induced cardiotoxicity in cancer patients

The efficacy of biomarkers indexes in comparison with Echocardiography in assessment of antracycline induced cardiotoxicity in cancer patients

Sh Keihanian,
F Ghaffari,
Z Fotokian,
Sh Asri,
M. THedayati,
MM Saravi

Keihanian S, Ghaffari F, Fotokian Z, Asri S, THedayati M, et al. The efficacy of biomarkers indexes in comparison with Echocardiography in assessment of antracycline induced cardiotoxicity in cancer patients. J Inflamm Dis. 2024;13(4):e155497. doi:

30
Jun
2017
Speckle Tracking Echocardiography for Detection of Early Myocardial Changes in Patients Treated with Anthracyclines

Speckle Tracking Echocardiography for Detection of Early Myocardial Changes in Patients Treated with Anthracyclines

Farid Mirzaee,
Armin Attar,
Mohammad Mohammadianpanah,
Firoozeh Abtahi,
Fatemeh Amirmoezi,
Alireza Moaref

Mirzaee F, Attar A, Mohammadianpanah M, Abtahi F, Amirmoezi F, et al. Speckle Tracking Echocardiography for Detection of Early Myocardial Changes in Patients Treated with Anthracyclines. Int Cardiovasc Res J. 2017;11(2):e10514. doi:

14
Sep
2026
Recent Progress in PET and SPECT Myocardial Perfusion Imaging: From Radiopharmaceuticals to Imaging Innovations

Recent Progress in PET and SPECT Myocardial Perfusion Imaging: From Radiopharmaceuticals to Imaging Innovations

Elham Sattarzadeh Khameneh,
Saeed Kakaei,
Yashar Noshadi,
Behrouz Alirezapour,
Fariba Johari Daha

Sattarzadeh Khameneh E, Kakaei S, Noshadi Y, Alirezapour B, Johari Daha F. Recent Progress in PET and SPECT Myocardial Perfusion Imaging: From Radiopharmaceuticals to Imaging Innovations. Iran J Pharm Res. 2026;25(1):e171684. doi: https://doi.org/10.5812/ijpr-171684

More by these authors

Mohammmad Mehdi ShiraziPubMedScholar
Ali Shabestani MonfaredPubMedScholar
Maryam ShahidiPubMedScholar
Mehrangiz AmiriPubMedScholar
Share
Cited by
Metrics